106 related articles for article (PubMed ID: 3004721)
41. Decreased basal cyclic adenosine 3',5'-monophosphate levels in Morris hepatoma 5123 t.c. (h).
Hickie RA; Walker CM; Croll GA
Biochem Biophys Res Commun; 1974 Jul; 59(1):167-73. PubMed ID: 4366958
[No Abstract] [Full Text] [Related]
42. Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.
Davies TF; Prudhoe K; Douglas AP
Br Med J; 1976 Apr; 1(6015):931-3. PubMed ID: 178399
[TBL] [Abstract][Full Text] [Related]
43. [Temporal relationship concerning changes in blood insulin, sugar and adenozine-3'5'-monophosphate following administration of glucagon to healthy subjects].
Czekalski S; Kosowicz J; Kozak W; Ruszkowska J
Pol Arch Med Wewn; 1975 Aug; 54(2):127-32. PubMed ID: 169513
[No Abstract] [Full Text] [Related]
44. [Effect of glucagon on plasma levels of 3',5'-adenosine monophosphate in patients with liver cirrhosis (author's transl)].
Malinovská V; Rysánek K; Bílková B; Martínek K; Ochmanová D
Cas Lek Cesk; 1977 Jul; 116(27):850-3. PubMed ID: 198133
[No Abstract] [Full Text] [Related]
45. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment.
Waller DG; Albano JD; Millar JG; Polak A
Clin Sci (Lond); 1984 May; 66(5):557-9. PubMed ID: 6323091
[TBL] [Abstract][Full Text] [Related]
46. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
[TBL] [Abstract][Full Text] [Related]
47. Glucagon stimulated plasma cyclic adenosine-3',5'-monophosphate in the differential diagnosis of jaundice.
Carstensen HE; Bruun E; Hansen OH; Marcussen H; Mollerup C
Surg Gynecol Obstet; 1979 Oct; 149(4):503-5. PubMed ID: 225837
[TBL] [Abstract][Full Text] [Related]
48. Effects of glucagon on plasma cyclic AMP in headache sufferers.
Caleri D; Nicolodi M; Andreini R; Curradi C; Sicuteri F
Cephalalgia; 1987; 7 Suppl 6():151-3. PubMed ID: 2832061
[No Abstract] [Full Text] [Related]
49. The effect of glucagon on adenosine 3',5'-monophosphate (cyclic AMP), glucose, insulin and growth hormone in the full term newborn and children.
Linarelli LG; Bobik C; Bobik J; Drash AL; Rubin HM
J Clin Endocrinol Metab; 1974 Sep; 39(3):411-7. PubMed ID: 4370447
[No Abstract] [Full Text] [Related]
50. Prevention of leukocyte migration inhibitory factor activity by glucagon.
Pereţianu D; Deleanu A; Lotreanu V; Mogoş A; Beşliu C; Tănase D
Med Interne; 1985; 23(1):63-6. PubMed ID: 2986274
[TBL] [Abstract][Full Text] [Related]
51. Glucagon effects on plasma cyclic AMP and other reactants in normals and low insulin responders.
Israelsson B; Fex G; Malmquist J; Nordén G
Acta Med Scand; 1978; 204(1-2):85-7. PubMed ID: 210635
[TBL] [Abstract][Full Text] [Related]
52. Arginine-induced insulin release in relation to the cyclic AMP system in man.
Efendic S; Cerasi E; Luft R
J Clin Endocrinol Metab; 1972 Jan; 34(1):67-72. PubMed ID: 4332668
[No Abstract] [Full Text] [Related]
53. The effect of glucagon on plasma cyclic AMP and glucose concentrations in patients with alcoholic cirrhosis.
Strange RC; Mjos OD; Henden T; Jynge P
Acta Med Scand; 1977; 202(1-2):87-8. PubMed ID: 197799
[TBL] [Abstract][Full Text] [Related]
54. The relationship between Mg2+-stimulated ATPase activity and glycogen content in rat liver.
Rubenstein B; Scholefield PG
Can J Biochem; 1969 Mar; 47(3):339-45. PubMed ID: 4305103
[No Abstract] [Full Text] [Related]
55. Increased excretion of urinary cyclic GMP in primary hepatoma and preneoplastic liver.
Shimamura J; Taketa K; Ito T; Shimada Y; Nagashima H
Acta Med Okayama; 1982 Oct; 36(5):331-40. PubMed ID: 6295071
[TBL] [Abstract][Full Text] [Related]
56. [Clinical significance of plasma c-AMP response to glucagon for the assessment of the prognosis in liver cirrhosis and hepatocellular carcinoma].
Kawai H; Kojima T; Takahashi K; Kano T; Muto Y
Nihon Shokakibyo Gakkai Zasshi; 1986 Feb; 83(2):170-9. PubMed ID: 3009934
[No Abstract] [Full Text] [Related]
57. Mechanism of plasma cyclic AMP response to hypoglycemia in man.
Brodows RG; Ensinck JW; Campbell RG
Metabolism; 1976 Jun; 25(6):659-63. PubMed ID: 178982
[TBL] [Abstract][Full Text] [Related]
58. Secretion of glucagon in liver cell carcinoma.
Ohneda A; Kobayashi T; Nihei J; Sakai T
Tohoku J Exp Med; 1985 May; 146(1):47-57. PubMed ID: 2992119
[TBL] [Abstract][Full Text] [Related]
59. [Pathogenetic investigations on a case of mauriac syndrome (author's transl)].
Tulzer W; Ploier R
Padiatr Padol; 1976; 11(2-2):356-63. PubMed ID: 184411
[TBL] [Abstract][Full Text] [Related]
60. [Effect of glucagon, insulin and serum of patients in hepatic coma on the phosphorylation of human erythrocyte membranes].
Rysánek K; Malinovská V; Bílková B
Vnitr Lek; 1979 Aug; 25(8):729-35. PubMed ID: 228487
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
